Company Profiles

driven by the PitchBook Platform

Savara Pharmaceuticals

Description

Developer of novel inhalation therapies intended to provide treatment for the patients with rare pulmonary conditions using inhaled antibiotics. The company's novel inhalation therapies produces inhaled dry powder form of vancomycin to treat Methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis patients enabling patients avail an improved clinical efficacy that reduces the risk of systemic drug-related side effects.

2007

Founded

PRIVATE

Status

11-50

Employees

Reverse Merger

Latest Deal Type

$51.9M

Total Amount Raised

19

Investors

Description

Developer of novel inhalation therapies intended to provide treatment for the patients with rare pulmonary conditions using inhaled antibiotics. The company's novel inhalation therapies produces inhaled dry powder form of vancomycin to treat Methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis patients enabling patients avail an improved clinical efficacy that reduces the risk of systemic drug-related side effects.

Website:

www.savarapharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

900 South Capital of Texas Highway Suite 150 Austin, TX 78746United States +1 (512) 961-1891
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Savara Pharmaceuticals's full profile, request a free trial.

Savara Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Savara Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Savara Pharmaceuticals Investors (19)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
37 VenturesVenture CapitalMinority000 0000000 0000
Aggie Angel NetworkOtherMinority000 0000000 0000
Carthona CapitalVenture CapitalMinority000 0000000 0000
Central Texas Angel NetworkAngel GroupMinority000 0000000 0000
Concho Valley Angel NetworkAngel GroupMinority000 0000000 0000
37 Ventures Venture Capital
Aggie Angel Network Other
Carthona Capital Venture Capital
Central Texas Angel Network Angel Group
Concho Valley Angel Network Angel Group

Savara Pharmaceuticals Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Robert NevilleCo-Founder, President, Chief Executive Officer & Chairman
David LowranceCo-Chief Financial Officer
Michael CieslaCo-Chief Financial Officer
Taneli Jouhikainen Ph.DChief Operating Officer & Co-Founder
Rebecca Waterbury JDDirector, Quality
Robert Neville Co-Founder, President, Chief Executive Officer & Chairman
David Lowrance Co-Chief Financial Officer
Michael Ciesla Co-Chief Financial Officer
Taneli Jouhikainen Ph.D Chief Operating Officer & Co-Founder
Rebecca Waterbury JD Director, Quality

Savara Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Christopher Hameetman JDTech Coast AngelsPresident000 0000
Joseph McCrackenSelfBoard Member000 0000
Nevan Elam JDSelfBoard Member000 0000
Richard HawkinsSelfBoard Member000 0000
Robert NevilleSavara PharmaceuticalsCo-Founder, President, Chief Executive Officer & Chairman000 0000
Christopher Hameetman JD President Tech Coast Angels
Joseph McCracken Board Member Self
Nevan Elam JD Board Member Self
Richard Hawkins Board Member Self
Robert Neville Co-Founder, President, Chief Executive Officer & Chairman Savara Pharmaceuticals
Request full access to PitchBook